You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Eldorado Gold Corporation (EGO) - free report >>
Anavex Life Sciences Corp. (AVXL) - free report >>
MongoDB, Inc. (MDB) - free report >>
Image: Bigstock
New Strong Buy Stocks for January 26th
Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:
Inhibikase Therapeutics, Inc. (IKT - Free Report) : This pharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 16% over the last 60 days.
Inhibikase Therapeutics, Inc. Price and Consensus
Inhibikase Therapeutics, Inc. price-consensus-chart | Inhibikase Therapeutics, Inc. Quote
Eldorado Gold Corporation (EGO - Free Report) : This mining and mineral exploration company has seen the Zacks Consensus Estimate for its current year earnings increasing 11.5% over the last 60 days.3
Eldorado Gold Corporation Price and Consensus
Eldorado Gold Corporation price-consensus-chart | Eldorado Gold Corporation Quote
MongoDB, Inc. (MDB - Free Report) : This database platform company has seen the Zacks Consensus Estimate for its current year earnings increasing 23.9% over the last 60 days.
MongoDB, Inc. Price and Consensus
MongoDB, Inc. price-consensus-chart | MongoDB, Inc. Quote
PagerDuty, Inc. (PD - Free Report) : This digital operations platform company has seen the Zacks Consensus Estimate for its current year earnings increasing 16.1% over the last 60 days.
PagerDuty Price and Consensus
PagerDuty price-consensus-chart | PagerDuty Quote
Anavex Life Sciences Corp. (AVXL - Free Report) : This biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 14.5% over the last 60 days.
Anavex Life Sciences Corp. Price and Consensus
Anavex Life Sciences Corp. price-consensus-chart | Anavex Life Sciences Corp. Quote
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.